Sundance Strategies Posts $1.02M Net Loss in Nine Months Ending December 2025
Sundance Strategies reported a net loss of $1.02 million for the nine months ending December 31, 2025, widening from a $966,000 loss in the same period a year earlier. Cash holdings fell 76% to $40,287 as the company burned through $322,050 in operations.
Sundance Strategies reported a net loss of $1.02 million for the nine months ending December 31, 2025, compared with a $966,000 loss in the prior-year period. The Nevada-incorporated company's quarterly loss narrowed to $220,708 in the third quarter of fiscal 2026, down from $260,993 a year earlier. Read more earnings reports.
Cash and cash equivalents dropped to $40,287 as of December 31, 2025, down 76% from $168,648 at the end of March 2025. The company burned $322,050 in operating activities during the nine-month period, a significant improvement from $825,240 in cash consumed in the comparable 2024 period.
Total assets fell to $53,787 at quarter-end from $178,203 nine months prior. The company raised $193,689 from financing activities during the nine months, well below the $755,000 brought in during the same period last year.
Operating losses improved to $341,057 for the nine months ending December 2025, compared with $503,457 in the prior-year period. Operating expenses for the nine-month period totaled $40,000.
Stockholders' deficit deepened to $6.93 million as of December 31, 2025, from $6.30 million at the end of March 2025. Retained deficit expanded to $39.5 million from $38.5 million over the same timeframe. Total liabilities increased to $6.98 million from $6.48 million.
The company reported a loss of $0.02 per share for the nine-month period, unchanged from the prior year on a basic and diluted basis. Shares outstanding remained flat at 43.1 million throughout the reporting period.
| Metric | Q3 FY2026 (Dec 31, 2025) | Q3 FY2025 (Dec 31, 2024) |
|---|---|---|
| Net Loss (Quarterly) | ($220,708) | ($260,993) |
| Net Loss (Nine Months) | ($1,019,322) | ($965,825) |
| Cash & Equivalents | $40,287 | $259,620 |
| Operating Cash Flow (Nine Months) | ($322,050) | ($825,240) |
| Total Assets | $53,787 | N/A |
| Stockholders' Deficit | ($6,930,837) | ($6,100,750) |
| EPS (Basic & Diluted, Nine Months) | ($0.02) | ($0.02) |